by Benzinga | February 26, 2026 2:10 am | US Markets
Castle Biosciences (NASDAQ:CSTL) is set to give its latest quarterly earnings report on Thursday, 2026-02-26. Here’s what investors need to know before the announcement. Analysts estimate that Castle Biosciences will report an earnings per share (EPS) of $-0.24....
by Benzinga | February 26, 2026 1:29 am | US Markets
Shares of MercadoLibre Inc (NASDAQ:MELI) tanked in early trading on Wednesday after the company reported mixed fourth-quarter results. Here are the key analyst insights: Cantor Fitzgerald analyst Deepak Mathivanan reiterated an Overweight rating, while lowering the...
by Benzinga | February 26, 2026 1:27 am | US Markets
Marcus (NYSE:MCS) is preparing to release its quarterly earnings on Thursday, 2026-02-26. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Marcus to report an earnings per share (EPS) of $0.11. The market...
by Benzinga | February 26, 2026 1:26 am | US Markets
Krispy Kreme (NASDAQ:DNUT) is set to give its latest quarterly earnings report on Thursday, 2026-02-26. Here’s what investors need to know before the announcement. Analysts estimate that Krispy Kreme will report an earnings per share (EPS) of $0.03. Krispy Kreme...
by Benzinga | February 26, 2026 1:25 am | US Markets
Ducommun (NYSE:DCO) is gearing up to announce its quarterly earnings on Thursday, 2026-02-26. Here’s a quick overview of what investors should know before the release. Analysts are estimating that Ducommun will report an earnings per share (EPS) of $0.94. The...
by Benzinga | February 26, 2026 1:24 am | US Markets
MBIA (NYSE:MBI) is gearing up to announce its quarterly earnings on Thursday, 2026-02-26. Here’s a quick overview of what investors should know before the release. Analysts are estimating that MBIA will report an earnings per share (EPS) of $-0.10. MBIA bulls...
by Benzinga | February 26, 2026 1:24 am | US Markets
Standard Motor Products (NYSE:SMP) will release its quarterly earnings report on Thursday, 2026-02-26. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate Standard Motor Products to report an earnings per share (EPS) of $0.47....
by Benzinga | February 26, 2026 1:21 am | US Markets
Amphastar Pharma (NASDAQ:AMPH) is set to give its latest quarterly earnings report on Thursday, 2026-02-26. Here’s what investors need to know before the announcement. Analysts estimate that Amphastar Pharma will report an earnings per share (EPS) of $0.91....
by Benzinga | February 26, 2026 12:29 am | Crypto News
Bitcoin (CRYPTO: BTC) appears to be tracking a familiar midterm-year bear market pattern, with one analyst warning that any early March strength may prove temporary rather than signaling a durable low. Bounce In Early March, But A Bull Trap? Crypto analyst Benjamin...
by Benzinga | February 26, 2026 12:27 am | Crypto News
XRP (CRYPTO: XRP) surged 9% on Wednesday while Cardano (CRYPTO: ADA) exploded 15% as both altcoins attempt major trend reversals. XRP Tests Breakout XRP is pressing against the upper boundary of a multi-week descending wedge with today’s high at $1.4747. The market...
by Benzinga | February 26, 2026 12:26 am | US Markets
Steven Madden, Ltd. (NASDAQ:SHOO) shares are trading lower after the company reported mixed fourth-quarter results and declined to provide FY26 earnings guidance due to a lack of clarity in U.S. tariff policy. Earnings Snapshot The apparel company reported adjusted...
by Benzinga | February 26, 2026 12:25 am | US Markets
Navitas Semiconductor Corp (NASDAQ:NVTS) shares are soaring on Wednesday after it reported fourth‑quarter revenue that topped expectations and issued first‑quarter guidance above analyst estimates. Navitas Semiconductor stock is showing exceptional strength. Why are...
by Benzinga | February 26, 2026 12:24 am | US Markets
Editor’s Note: This article has been updated to reflect that Ferguson’s adjusted EPS beat the consensus estimate. Ferguson Enterprises Inc. (NYSE:FERG) on Tuesday reported fourth-quarter FY25 results. Earnings Snapshot Sales rose 3.6% year over year (Y/Y) to $7.50...
by Benzinga | February 26, 2026 12:24 am | US Markets
Lowe’s Companies, Inc. (NYSE:LOW) stock declined Wednesday after the home improvement retailer posted fourth-quarter results and delivered a cautious fiscal 2026 outlook, highlighting ongoing strain in the housing market. Earnings Snapshot Net sales rose 10.9% to...
by Benzinga | February 26, 2026 12:22 am | US Markets
The earnings results for Penumbra (NYSE:PEN) for Q4 were made public on Wednesday, February 25, 2026 at 04:00 PM. Here’s a comprehensive overview of the announcement. Earnings Penumbra beat estimated earnings by 5.36%, reporting an EPS of $1.18 versus an...
by Benzinga | February 26, 2026 12:21 am | US Markets
GigaCloud Tech (NASDAQ:GCT) will release its quarterly earnings report on Thursday, 2026-02-26. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate GigaCloud Tech to report an earnings per share (EPS) of $0.77. The announcement...
by Benzinga | February 26, 2026 12:20 am | US Markets
Novavax (NASDAQ:NVAX) is gearing up to announce its quarterly earnings on Thursday, 2026-02-26. Here’s a quick overview of what investors should know before the release. Analysts are estimating that Novavax will report an earnings per share (EPS) of $-0.56....
by Benzinga | February 26, 2026 12:20 am | US Markets
ImmunityBio Inc. (NASDAQ:IBRX) shares are down on Wednesday, cooling off from a huge up move as the company is reportedly experiencing significant revenue growth. This surge follows a strong performance driven by the sales of its lead drug, Anktiva, which has gained...
by Benzinga | February 26, 2026 12:19 am | US Markets
Ginkgo Bioworks Holdings (NYSE:DNA) is preparing to release its quarterly earnings on Thursday, 2026-02-26. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Ginkgo Bioworks Holdings to report an earnings per...
by Benzinga | February 26, 2026 12:17 am | US Markets
Akebia Therapeutics (NASDAQ:AKBA) will release its quarterly earnings report on Thursday, 2026-02-26. Here’s a brief overview for investors ahead of the announcement. Analysts anticipate Akebia Therapeutics to report an earnings per share (EPS) of $-0.05....
